Abstract
The prognosis of adults with acute lymphocytic leukemia has improved over the last two decades. With modern intensive chemotherapy regimens similar to those of pediatric acute lymphocytic leukemia, the complete response rate is 75% to 85%, with a long-term, disease-free survival rate of 20% to 35%. We review the clinical, laboratory, and prognostic features of adult acute lymphocytic leukemia and discuss the results of therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 52-59 |
| Number of pages | 8 |
| Journal | Texas medicine |
| Volume | 90 |
| Issue number | 1 |
| State | Published - Jan 1 1994 |
ASJC Scopus subject areas
- General Medicine